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Abstract. 
 
An active involvement of blood–brain bar-
rier endothelial cell basement membranes in develop-
ment of inﬂammatory lesions in the central nervous sys-
tem (CNS) has not been considered to date. Here we
investigated the molecular composition and possible
function of the extracellular matrix encountered by ex-
travasating T lymphocytes during experimental autoim-
mune encephalomyelitis (EAE).
Endothelial basement membranes contained laminin
 
8 (
 
a
 
4
 
b
 
1
 
g
 
1) and/or 10 (
 
a
 
5
 
b
 
1
 
g
 
1) and their expression
was inﬂuenced by proinﬂammatory cytokines or angio-
static agents. T cells emigrating into the CNS during
EAE encountered two biochemically distinct basement
membranes, the endothelial (containing laminins 8 and
10) and the parenchymal (containing laminins 1 and 2)
basement membranes. However, inﬂammatory cuffs oc-
curred exclusively around endothelial basement mem-
branes containing laminin 8, whereas in the presence of
laminin 10 no inﬁltration was detectable. In vitro assays
using encephalitogenic T cell lines revealed adhesion to
laminins 8 and 10, whereas binding to laminins 1 and 2
could not be induced. Downregulation of integrin 
 
a
 
6 on
cerebral endothelium at sites of T cell inﬁltration, plus a
high turnover of laminin 8 at these sites, suggested two
possible roles for laminin 8 in the endothelial basement
membrane: one at the level of the endothelial cells re-
sulting in reduced adhesion and, thereby, increased
penetrability of the monolayer; and secondly at the
level of the T cells providing direct signals to the trans-
migrating cells.
Key words: laminin • experimental autoimmune en-
cephalomyelitis • endothelium • basement membranes
• inﬂammation
 
Introduction
 
One of the major functional components of all basement
membranes is the laminin family of glycoproteins which
influence motility, proliferation, and differentiation of
many cell types (Timpl and Brown, 1994; Ekblom and
Timpl, 1996). Laminins are heterotrimers composed of an
 
a
 
, 
 
b
 
, and 
 
g 
 
chain. To date, 5 
 
a
 
, 3 
 
b
 
, and 3 
 
g
 
 chains have
been reported which can combine to form up to 12 differ-
ent laminin isoforms (Timpl et al., 1979; Hunter et al.,
1989; Paulsson and Saladin, 1989; Ehrig et al., 1990; Miner
et al., 1995; Frieser et al., 1997; Koch et al., 1999). How-
ever, in vitro cellular interactions are well defined only for
laminin 1 (Aumailley and Smyth, 1998) and, to a lesser ex-
tent, for laminins 2 and 5, which have restricted distribu-
tions in vivo. Only two isoforms, laminins 8 (composed of
laminin 
 
a
 
4, 
 
b
 
1, and 
 
g
 
1) and 10 (composed of laminin 
 
a
 
5,
 
b
 
1, and 
 
g
 
1) are found in endothelial basement membranes
of most tissues (Sorokin et al., 1994, 1997a; Frieser et al.,
1997). Further, we have shown that laminin 
 
a
 
4 expression
by endothelial cells in vitro is strongly upregulated by
proinflammatory cytokines such as interleukin (IL)
 
1
 
-1
(Frieser et al., 1997), suggesting a role in inflammatory
events. Blood vessels in the central nervous system (CNS)
have also been reported to express laminins 1 and 2
(Jucker et al., 1996; Powell and Kleinman, 1997; Tian et
al., 1997), which are not detected in blood vessel basement
membranes elsewhere and which may be related to their
highly specialized structure. The differential expression of
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laminin isoforms under different endothelial cell activa-
tion states has prompted us to investigate the role of lami-
nins in inflammatory events. We have used a murine
experimental autoimmune encephalomyelitis (EAE), an
inflammation model with a well defined immunopathol-
ogy and clinically relevant similarity to the human disease,
multiple sclerosis.
EAE can be induced in susceptible mouse strains by im-
munization with myelin proteins, myelin protein frag-
ments, or by adoptive transfer of myelin reactive CD4
 
1
 
 T
cell blasts (Engelhardt, 1997). A critical step in this inflam-
mation is the extravasation of leukocytes from the blood
stream into the CNS parenchyma, which involves autoag-
gressive T cell adhesion to and migration through the
endothelial cell monolayer of the postcapillary venules.
However, after passage across the endothelial cell mono-
layer, leukocytes still face the endothelial cell basement
membrane and the subjacent glia limitans consisting of as-
trocyte endfeet and associated basement membrane (Wol-
burg and Risau, 1995).
Ultrastructurally, at least two basement membranes can
be identified in association with larger blood vessels in the
brain, an endothelial and an astroglial basement mem-
brane (Wolburg and Risau, 1995). In addition, the epithe-
lium of the meninges coinvaginates with blood vessels
from the surface of the brain and contributes to the astro-
glial basement membrane (Alcolado et al., 1988; Wolburg
and Risau, 1990; Zhang et al., 1990; Wolburg and Risau,
1995). Collectively, the astroglial basement membrane
and the meningeal epithelium basement membrane are
known as the parenchymal basement membrane, as they
delineate the border to the brain parenchyma. The endo-
thelial cell and parenchymal basement membranes define
the inner and outer limits of the perivascular space where
leukocytes accumulate during acute EAE before infiltrat-
ing the brain parenchyma (Cross et al., 1993; Engelhardt
et al., 1997). However, studies to date have not distin-
guished between penetration of the endothelial cell base-
ment membrane and the process of parenchymal invasion
across the glia limitans. There is evidence that suggests
these two steps are distinct and independent of one an-
other: in EAE induced in macrophage-depleted mice
(Tran et al., 1998) or in tumor necrosis factor (TNF)-defi-
cient mice (Körner et al., 1997), the inflammatory infil-
trate becomes entrapped in the perivascular space and
parenchymal infiltration is prevented, indicating that pro-
gression through the astrocyte basement membrane is
functionally distinct from endothelial cell basement mem-
brane transmigration.
In this study, we define the extracellular matrix barriers
encountered by extravasating T cells and the steps in-
volved in their transmigration using two different murine
EAE models. Further, the use of encephalitogenic T cell
lines in in vitro adhesion assays has permitted definition of
cell–matrix interactions permissive or restrictive for T cell
extravasation. Our data demonstrate that endothelial cell
basement membranes containing laminin 8 are permissive
for T cell transmigration, whereas those containing lami-
nin 10 are restrictive for T cell transmigration. Penetration
of the parenchymal basement membrane, characterized by
the expression of laminins 1 and 2, which are not adhesive
for T cells, occurs only after disruption of this outer bar-
 
rier, probably via proteolysis and involving matrix metal-
loproteinases (MMPs; Graesser et al., 2000).
 
Materials and Methods
 
Animals
 
Female SJL/N and C57Bl/6 mice between 3 and 4 wk of age were obtained
from Bomholdgard Breeding.
 
Induction of EAE and PLP T Cell Lines
 
EAE was induced in SJL/N mice by immunization with syngeneic spinal
cord homogenate in CFA (Engelhardt et al., 1997) or C57Bl/6 mice using
myelin oligodendrocyte glycoprotein peptide (Gardinier et al., 1992) as
described previously. Animals were observed daily and neurological defi-
cits were scaled as follows: 1
 
1
 
, flaccid tail; 2
 
1
 
, hind limb weakness; 3
 
1
 
,
severe hind limb weakness; 4
 
1
 
, hind quarter paralysis; and 5
 
1
 
, forelimb
weakness. At least three mice at each stage were examined.
Protein–lipid–protein (PLP)-specific T cell lines were established as de-
scribed in detail previously (Engelhardt et al., 1997, 1998).
 
Primary Antibodies
 
Primary antibodies to extracellular matrix and cell surface adhesion mole-
cules used in immunofluorescence and cell adhesion studies are listed in
Table I.
Rat anti–mouse platelet endothelial cell adhesion molecule (PECAM)-1
(MEC13.3; Vecchi et al., 1994) was used as an endothelial cell marker
(BD PharMingen); rat anti–mouse CD45 (leukocyte common antigen;
Ly-5) was used to detect leukocytes (30-F11; BD PharMingen); Cy3 con-
jugate anti–mouse glial fibrillar acidic protein (GFAP; Sigma-Aldrich)
was used as a marker for astrocyte endfeet; and Cy3-coupled anti–mouse
smooth muscle actin (Sigma-Aldrich), which in the CNS can be used to
distinguish arteries and arterioles from veins, capillaries, and postcapillary
venules (Nehls and Drenckhahn, 1991; Nehls et al., 1992; Boado and Par-
dridge, 1994).
 
Immunofluorescence
 
Tissues were prepared and immunofluorescently stained as described pre-
viously (Sorokin et al., 1992). Bound antibodies were visualized using
FITC- or Texas red–conjugated goat anti–rat, goat anti–guinea pig, or
goat anti–rabbit IgG second antibodies (Dianova). In the case of anti–
 
b
 
-dystroglycan stainings, unfixed sections were used. Stained sections
were examined using confocal laser scanning microscopy (model 1000;
Bio-Rad Laboratories).
 
Isolation of Laminins 8 and 10
 
Mouse laminin 8 (composed of 
 
a
 
4
 
b
 
1
 
g
 
1 chains) was isolated from the con-
ditioned media of 3T3 fibroblasts and the MC3T3-G2/PA6 preadipocyte
cell line using a combination of an ion exchange chromatography (PO-
ROS 20 HQ column; Applied Biosystems) and immunoaffinity chroma-
tography (CNBr-Sepharose) with a rat anti–mouse laminin 
 
g
 
1 chain mono-
clonal antibody raised in our laboratory (3E10). In brief, conditioned
medium was diluted 1:3 in 50 mM Tris-HCl buffer, pH 8, and concen-
trated on an ion exchange column, POROS 20 HQ column. After dialysis
against PBS, the protein solution was subjected to immunoaffinity chro-
matography with the rat monoclonal anti-laminin 
 
g
 
1 antibody (3E10). The
affinity column was prepared by coupling 2 mg purified antibody to
CNBr-Sepharose. Bound protein was eluted batchwise from the affinity
material with 0.1 M triethylamine, pH 11.5, neutralized, and dialysed
against 20 mM Tris-HCl, pH 8. Before final dialysis against PBS, gelatin-
Sepharose was used to absorb fibronectin and a small POROS 20 HQ col-
umn was used for sample concentration.
Laminin 10 was isolated from human placenta by affinity chromatogra-
phy using mouse anti–human 
 
g
 
1 (D18) (Sanes et al., 1990) and 
 
a
 
5 (4C7)
monoclonal antibodies (Leivo and Engvall, 1988) as described previously
(Lindblom et al., 1994; Sixt et al., 2001). Mouse anti–human laminin 
 
b
 
2
(C4) antibody was used to immunoabsorb laminin 
 
b
 
2–containing com-
plexes where necessary. Before immunopurification, 50–100 gm human
placenta was homogenized twice on ice in 300 ml 50 mM Tris-HCl, pH 7.5,
plus 150 mM NaCl and protease inhibitors, and finally in 50 mM Tris-HCl, 
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pH 7.5, plus 300 mM NaCl and 20 mM EDTA. After at least 3 h of extrac-
tion at 4
 
8
 
C with gentle rolling, the placenta extract was clarified by centrif-
ugation and dialysed against PBS. Further purification steps were per-
formed essentially as described for laminin 8.
The chain composition of the laminin 8 and 10 preparations was as-
sessed by immunoblotting and ELISA using laminin chain–specific anti-
bodies (Table I), whereas the purity of the preparations was assessed by
silver-stained SDS-PAGE under reducing conditions. The laminin 8 prep-
aration was found to contain only laminin 
 
a
 
4, 
 
b
 
1, and 
 
g
 
1 chains (Sixt et al.,
2001), whereas the laminin isolated from human placenta contained pre-
dominantly laminin 
 
a
 
5, 
 
b
 
1, and 
 
g
 
1 chains (laminin 10), plus a weak lami-
nin 
 
b
 
2 chain band in silver staining (laminin 11) as shown in Sixt et al.
(2001). Laminin 11 represented 
 
,
 
5% of the human laminin preparation.
 
Endothelial Cell Lines
 
Mouse endothelial cell lines derived from brain capillaries (bEND3) and a
skin hemangioma (sEND1) were as described previously (Frieser et al.,
1997; Sorokin et al., 1994, 1997a). Both cells were grown in DME supple-
mented with 10% fetal calf serum at 37
 
8
 
C and 7.5% CO
 
2
 
 in a water-satu-
rated environment.
 
Northern Blot Analysis
 
mRNA extraction and Northern blot analyses were performed as de-
scribed previously (Sorokin et al., 1997a,b). RNA was isolated from unac-
tivated endothelial cell lines (bEND3 and sEND1), and cell lines activated
for 4 h at 37
 
8
 
C with 75 U/ml TNF-
 
a
 
 (BD PharMingen) or 10 ng/ml IL-1
 
b
 
(Biomol), or treated for 3 d with 4 
 
m
 
g/ml hydroxymethylprogesterone
(Sigma-Aldrich) and freshly dissected control and EAE brains (clinical
scores, 
 
1
 
4/
 
1
 
5). Hybridizations were performed with the following 
 
32
 
P-
labeled specific cDNA probes: laminin 
 
a
 
1 covering nucleotides 7786–9286
(Schuler and Sorokin, 1995); laminin 
 
a
 
2 covering nucleotides 6420–6895
(Schuler and Sorokin, 1995); laminin 
 
a
 
4 covering nucleotides 4720–5311
(Frieser et al., 1997); laminin 
 
a
 
5 covering nucleotides 3962–4623 (Sorokin
et al., 1997b); or with a glyceraldehyde-3-phosphate dehydrogenase
(GADPH)-specific probe (Sorokin et al., 1997b).
 
In Situ Hybridization
 
In situ hybridization of E16 and E18 mouse embryos and newborn and
adult brains was performed as described previously (Sorokin et al.,
1997a), using the cDNA probes for laminin 
 
a
 
1, 
 
a
 
2, and 
 
a
 
4 chains de-
scribed above for Northern blot analysis, plus an endothelial cell–specific
probe, flk-1 (Breier et al., 1992).
 
Adhesion Assays
 
In vitro cell attachment assays were performed as described previously
(Goodman et al., 1987; Schuler and Sorokin, 1995), using laminins 8 and
 
10 prepared as described above, laminin 1 isolated from the Engelbreth-
Holm-Swarm (EHS) mouse tumor (Paulsson et al., 1987), and laminin 2
isolated from mouse hearts (Paulsson and Saladin, 1989) as substrates.
PLP encephalotigenic T cell lines (1 d after restimulation) were washed
with PBS and 5 
 
3 
 
10
 
4
 
 cells were added per well in 100 
 
m
 
l adhesion buffer
(RPMI, 0.5% BSA, 10 mM Hepes, pH 7.5). The number of adherent cells
after 30 min of incubation at 37
 
8
 
C without shear stress was determined by
colorimetric analysis of lysosomal hexosaminidase (OD
 
405
 
; Landegren,
1984). Since leukocytes are activated by chemokines and cytokines are re-
leased at sites of inflammation in vivo, attachment assays were performed
with nonactivated and PMA-activated (100 ng/ml) cells.
To assess which cellular receptors mediated interactions with extracel-
lular matrix molecules, inhibition studies were carried out using specific
antibodies to integrin subunits (see Table I). Cells were preincubated with
given concentrations of antibodies against integrin subunits or control an-
tibodies for 30 min before addition to protein-coated microtiter plates.
Experiments were carried out with different laminin isoforms plated at a
concentration of 20 
 
m
 
g/ml. The experimental procedure was otherwise as
described in detail elsewhere (Frieser et al., 1996).
The percentage of cells which bound specifically to the coating sub-
strate was determined as follows: ([OD
 
405
 
 of total bound cells 
 
2
 
 OD
 
405
 
 of
BSA bound cells]/OD
 
405
 
 of 50,000 applied) 
 
3
 
 100 
 
5 
 
percentage of specific
binding.
 
Results
 
Basement Membranes Associated with Brain Blood Vessels
 
In the noninflamed brain the cellular and extracellular ma-
trix layers of the blood vessels appear as a single structure
at the light microscope level and are distinguishable only
by electron microscopy. However, during early stages of
inflammation or in animals with low clinical EAE scores
(1
 
1
 
 to 2
 
1
 
), leukocytes accumulate in the perivascular
space between the endothelial and the astrocyte endfeet
basement membranes, rendering them distinguishable at
the light microscope level and allowing the clear identifi-
cation of the localization of laminin chains (Fig. 1, A–C).
In EAE, local inflammations develop around blood ves-
sels, hence only a fraction of blood vessels develop a
perivascular cuff, allowing analysis of vessels with and
without infiltrates in the same section (Fig. 1, B and C).
Double staining with a pan–laminin 1 antibody, which rec-
ognizes laminin 
 
a
 
1, 
 
b
 
1, and 
 
g
 
1 chains equally well and
 
Table I. Specificities and Sources of Antibodies Used
 
Specificity Species Antibody Source/reference
 
Laminin 
 
a
 
1 Rat 198 Sorokin et al., 1992
Laminin 
 
a
 
1 Rabbit 317 Durbeej et al., 1996
Laminin 
 
a
 
2 Rat 4H8-2 Schuler and Sorokin, 1995
Laminin 
 
a
 
4 Rat 341 Ringelmann et al., 2000
Laminin 
 
a
 
4 Rabbit 377 Sorokin et al., 2000
Laminin 
 
a
 
3 Rabbit Lam
 
a
 
3 Galliano et al., 1995
Laminin 
 
a
 
5 Rat 4G6 Sorokin et al., 1997a
Laminin 
 
a
 
5 Rabbit 405 Sorokin et al., 2000
Laminin 
 
b
 
1 Rat 3E10 Sixt et al., 2001
Laminin 
 
g
 
1 Rabbit N283 Mayer et al., 1993
Laminin 
 
b
 
2 Guinea pig GP-5 Patton et al., 1997
Pan–laminin 1 Rabbit 308 Sorokin et al., 1990; Ringelmann et al., 2000 
Integrin 
 
a
 
6 Rat GoH3 Sonnenberg et al., 1988
Integrin 
 
a
 
3 Rabbit 340 Valles et al., 1996
Integrin 
 
a
 
3 Rabbit C-18 Santa Cruz Biotechnology, Inc.
Integrin 
 
a
 
7 Rabbit 242 Echtermeyer et al., 1996; Mayer et al., 1997
Integrin 
 
b
 
1 Hamster Ha2/5 Lenter and Vestweber, 1994; BD PharMingen
Integrin 
 
b
 
4 Rat 346-11A Lenter and Vestweber, 1994; BD PharMingen
 
b
 
-Dystroglycan Mouse NCL-43DAG Novo Castra 
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hence any laminin containing at least one of these chains
and anti–PECAM-1 (Fig. 1 B) or the leukocyte marker,
anti-CD45 (Fig. 1 C), reveals the PECAM-1–positive en-
dothelial cell monolayer and the separate inner endothe-
lial and outer parenchymal basement membranes at sites
of infiltration (Fig. 1 B, inset), but not where no infiltra-
tion has occurred (Fig. 1, B and C).
Stainings with specific monoclonal and/or polyclonal
antibodies for the five known laminin 
 
a
 
 chains (
 
a
 
1–5)
showed that all 
 
a
 
 chains except laminin 
 
a
 
3 are expressed
in association with blood vessels. However, the different
laminin 
 
a
 
 chains were not colocalized in the same base-
ment membrane and they had different cellular origins
(Figs. 2 and 3). Fig. 2 shows consecutive sections of an in-
flamed brain double stained for pan–laminin 1 and CD45
to define sites of mononuclear infiltration (Fig. 2 A), dou-
ble stained for individual laminin 
 
a
 
 chains (Fig. 2, B–F), or
stained for 
 
a
 
-smooth muscle actin alone (Fig. 2 G). Only
laminin 
 
a
 
4 and 
 
a
 
5 occurred in the inner endothelial cell
basement membrane (Fig. 2, B and C), whereas laminin 
 
a
 
1
and 
 
a
 
2 were restricted to the parenchymal basement
membrane (Fig. 2, D–F). The inset in Fig. 2 B shows a
double staining for PECAM-1 and laminin 
 
a
 
1, revealing
clear separation of immunoreactivity, which was also ob-
served for laminin 
 
a
 
2/PECAM-1 double stainings. One of
the most striking findings was the absence of laminin a5 in
the endothelial cell basement membrane where mononu-
clear infiltration had occurred (compare Fig. 2, A and C).
Spinal cords and brains of mice afflicted with EAE with
clinical scores of 11 to 51 showed essentially the same
pattern of results. Recruitment of inflammatory cells, as
defined by CD45 reactivity, was consistently localized
around blood vessels where only laminin a4 could be de-
tected in the endothelial cell basement membrane (com-
pare Fig. 2, A and B). No infiltrate was observed around
blood vessels where both laminin a4 and a5 were detected
Figure 1. Cell layers and basement membranes
which occur in association with blood vessels in
the CNS. (A) Schematic representation of blood
vessels showing the inner endothelial cell layer
and its basement membrane (BM), bordered by
epithelial meningeal cells and associated extra-
cellular matrix and outer astroglial basement
membrane and astrocyte endfeet. Collectively,
the meningeal component and astroglial base-
ment membrane are termed the parenchymal
basement membrane. (B) Double staining of
EAE brains (clinical scores 11 to 12) for PE-
CAM-1 (red) and pan–laminin 1 antibody (PAN-
LM1, green) which recognizes laminin a1,  b1,
and  g1 chains and thereby many laminin iso-
forms. Inset shows pan–laminin 1 staining alone.
At sites of mononuclear infiltration the internal
endothelial cell layer, bordered by its basement
membrane, is distinct from the outer parenchy-
mal basement membrane (arrowhead), whereas
where no infiltration has occurred these two
basement membranes are indistinguishable (ar-
rows). (C) Double staining of EAE brains (clini-
cal scores 13 to 14) with the leukocyte marker,
CD45 and pan–laminin 1 antibody, demonstrat-
ing infiltrating mononuclear cells accumulating in
the perivascular space and penetrating the outer
parenchymal basement membrane. Bar, 50 mm.Sixt et al. Laminins in T Cell Recruitment in EAE 937
(compare Fig. 2, A–C). Further, mononuclear infiltration
occurred at sites where the parenchymal basement mem-
brane contained both laminin a1 and a2 chains (Fig. 2,
D–F), but where no smooth muscle actin reactivity was de-
tectable (Fig. 2 G).
Laminin  a2 immunoreactivity was more widespread
than that of laminin a1 and was detected in association
with all blood vessels within the brain (Fig. 2, D–F). This is
well illustrated in Fig. 3, A–C, which shows laminin a1/a2
double staining of a single microvessel, revealing the more
extensive staining for laminin a2 and the restriction of
laminin  a1 to a portion of the vessel. The close association
of the laminin a2 and GFAP (Fig. 3, D–F) suggests that
laminin a2 is expressed by astrocytes and that the protein
Figure 2. Confocal microscopy analysis of consecutive sections of EAE brains (clinical score 11 to 12) double stained for pan–lami-
nin 1 (PAN-LM1) and CD45 (A), laminins a1 and a4 (B), laminins a1 and a5 (C), laminins a1 and a2 (D–F), or a-smooth muscle actin
(SMA) alone (G). Inset in B shows double staining for PECAM-1 and laminin a1 at sites of monoclear infiltration. Superimposed im-
ages are shown in A–D; individual images for laminins a1 and a2 are shown in E and F, respectively. Arrowheads in all sections mark
the same blood vessel where mononuclear infiltration has occurred, revealing the presence of laminin a4 alone in the endothelial cell
basement membrane. The arrows mark vessels where no infiltration has occurred, revealing the presence of laminin a4 and a5 in the
endothelial cell basement membrane and a-smooth muscle actin reactivity (G). Note the presence of laminin a1 and a2 in parenchymal
basement membrane only (B–F) and the restricted distribution of laminin a1 (D and E). Double staining for laminin b1 and b2 (H) and
for laminin g1 alone (I) revealed the presence of laminin b1 and g1 chains in association with all blood vessels, whereas laminin b2 is re-
stricted to larger vessels. Inset in H shows laminin b1 staining at a site of mononuclear infiltration, localizing this chain to endothelial
and parenchymal basement membranes. The same pattern of results was observed for laminin g1. Bar, 80 mm.The Journal of Cell Biology, Volume 153, 2001 938
is deposited at their endfeet. Laminin a1 chain immunore-
activity was restricted to vessels with diameters .10 mm
throughout the CNS (Fig. 2, D and E) and was contiguous
with pia mater epithelium covering the brain, disappearing
abruptly in the precapillary region of arteries and veins
(Fig. 3, A and C). No laminin a1 staining was detected in
association with capillaries (Fig. 2 E).
To define the laminin isoforms localized in endothelial
and parenchymal basement membranes, stainings were
also performed for laminin b1, b2, and g1 chains, revealing
the presence of laminin b1 (Fig. 2 H) and g1 (Fig. 2 I) in
endothelial and parenchymal basement membranes (Fig. 2
H, inset), whereas laminin b2 was restricted to the smooth
muscle layer of larger blood vessels (Fig. 2 H). This sug-
gests that laminin 8 (a4b1g1) and 10 (a5b1g1) are the
main laminin isoforms in the endothelial cell basement
membrane, whereas laminin 1 (a1b1g1) and 2 (a2b1g1)
occur in the parenchymal basement membrane.
Cellular Origins of Laminin Chains
In situ hybridization experiments were performed to define
the cellular origin of the laminin a chains. The low turn-
over of most laminin a chains in adult tissues (data not
shown) made it necessary to compare the expression pat-
terns for the individual laminin a chains in embryonic and/
or newborn brains (Fig. 4). In E16, E18, and, more weakly,
in newborn mouse brains, laminin a1 mRNA was not ex-
pressed by endothelial cells, but rather by the lepto-
meningeal cells of the pia mater that encase the brain and are
infolded from the brain surface (Fig. 4, A and B), correlat-
ing well with the protein distribution data. In situ hybrid-
ization of E16 and E18 mouse brains revealed a strong
laminin a2 mRNA signal in the meninges (data for E16 is
shown in Fig. 4 C), which is most likely to be a glial product
(Sixt, M., and L. Sorokin, manuscript in preparation).
Laminin  a4 mRNA was expressed in all endothelial cells of
embryonic, newborn, and adult vessels (data for E16 brain
are shown in Fig. 4, E and F), suggesting a high turnover of
this molecule even in the mature blood vessel basement
membrane. Our previous studies have shown that laminin
a5 mRNA appears in endothelium of the brain (and other
tissues) only 3–4 wk after birth and remains weak in the
adult brain endothelium (Sorokin et al., 1997a).
Laminin Receptor Expression in Normal
and Inflamed Blood Vessels
Immunoreactivity for the major laminin-binding receptors
(a6b1,  a3b1,  a7b1,  a6b4, and dystroglycan; Delwel and
Sonnenberg, 1996; Talts et al., 1999; Kikkawa et al., 2000;
Kortesmaa et al., 2000) was analyzed in inflamed and non-
inflamed blood vessels. Due to the absence of antibodies to
a-dystroglycan which function well in immunofluorescence
of tissues other than skeletal muscle, it was necessary to
utilize a b-dystroglycan–specific antibody for investigations
of a-dystroglycan localization. b- and a-dystroglycan are
products of the same gene and colocalize in most tissues
(Henry and Campbell, 1998). However, there are reports
of b-dystroglycan expression in the absence of a-dystrogly-
can (Saito et al., 1999; Losasso et al., 2000).
Integrin a6 and b-dystroglycan were prominent in CNS
blood vessels (Fig. 5, A–C), whereas no staining was ob-
served for integrin a3,  a7, and b4 subunits (data not
shown; Pinkstaff et al., 1999). Confocal microscopy re-
vealed a mutually exclusive expression of integrin a6 and
b-dystroglycan on all blood vessels except capillaries (Fig.
5, A–C). It was not possible to perform double staining for
integrin a6 and PECAM-1, as both were rat antibodies;
however, comparison of the staining patterns for the two
molecules revealed identical patterns. This suggests ex-
pression of integrin a6 on PECAM-1–positive endothe-
lium in close association with laminin a4 and a5, but not
with the laminin a1 and a2 chains of the parenchymal
basement membranes (double staining for laminin a1 and
integrin a6 is shown in Fig. 5, D–F). This pattern was even
more distinct in EAE brains, where the presence of a
perivascular cuff allowed clear identification of integrin a6
expression on endothelium in close association with the
laminin a4– and/or a5–containing basement membrane
(data for integrin a6 is shown in Fig. 5 F, inset). In con-
trast, b-dystroglycan immunostaining was restricted to as-
trocyte endfeet, in close association with GFAP staining
(not shown) and laminin a2 immunoreactivity, and was
distinct from that of laminin a4 and a5 (reconstruction of
serial optical sections for laminin a4/b-dystroglycan dou-
ble staining is shown in Fig. 5, G–I).
At early stages of EAE and in control brains, all blood
vessels showed an intense and continuous staining for inte-
grin a6 (Fig. 5, D and F), whereas at advanced stages of
EAE integrin a6 immunoreactivity on endothelium was
significantly less intense and discontinuous (Fig. 5 F, in-
set). b-Dystroglycan did not appear to be altered in its ex-
pression pattern or intensity. However, at sites of leuko-
cyte infiltration this was difficult to assess because of high
background staining of this mouse monoclonal antibody in
EAE brains (data not shown).
Figure 3. Confocal microscopy analysis of individual blood ves-
sels in the CNS double stained for laminin a1 and a2 (A–C) or
laminin a2 and GFAP (D–F). Superimposed images are shown in
A and D; individual images are shown in B, C, E, and F. Note the
restricted distribution of laminin a1 which disappears at the pre-
capillary level (A–C). Laminin a2 localizes at the GFAP-positive
astrocyte endfeet (D and E). Bars: (A–C) 8 mm; (D–F) 12 mm.Sixt et al. Laminins in T Cell Recruitment in EAE 939
Integrin  b1 immunoreactivity was more widespread
than that of integrin a6 as it occurred on both endothelium
and astrocyte endfeet (compare Fig. 5, F and K), and was
strong on endothelium and weaker on astrocyte endfeet
(Fig. 5, J–L). In EAE brains, venules with perivascular in-
flammatory cells staining for integrin b1 were not altered
(Fig. 5 K, inset).
Northern Blot Analysis—Whole Brains
To investigate the possibility that laminin a5 mRNA is
downregulated in EAE brains, Northern blot analysis was
performed on whole brains of control and EAE mice (clin-
ical score 41/ 51) using laminin a1–, a2–, a4–, and a5–
specific probes. Laminin a1 and a2 mRNA were not
detectable in either control or EAE brains, whereas the
12-kb laminin a5 mRNA was detectable after 6 d of expo-
sure and a distinct 6.5-kb laminin a4 mRNA signal was
seen after 24 h of exposure (Fig. 6 A). No difference was
apparent between control and EAE brains.
Northern Blot Analyses of Cultured Endothelial Cells
To test whether laminin isoform expression in microvascu-
lar endothelium is regulated by proinflammatory cyto-
kines present at sites of mononuclear infiltration (for
review see Sedgwick et al., 2000), mouse brain capillary–
derived (bEND3) and vein-derived (sEND1) endothelial
cell lines were investigated by Northern blot analysis.
Consistent with the in vivo results, both endothelial cell
lines expressed laminin a4 and a5 mRNA (Fig. 6, B and
C). Laminin a4 mRNA was upregulated in sEND1 after
Figure 4. In situ hybridiza-
tion of consecutive sections
of E16 embryonic mouse
brains with probes specific
for laminin a1 (A and B), a2,
(C and D), a4 (E and F), and
an endothelial cell–specific
probe, flk-1 (G and H). Data
shown are for similar areas,
encompassing meninges (ar-
rows) and a portion of the
cortex of the cerebellum.
Similar results were observed
for E18 embryos and, in the
case of laminin a4, also for
newborn and adult tissues.
Laminin  a1 mRNA was ex-
pressed by the lepto-
meningeal cells of the pia
mater that encase the brain
and are infolded from the
brain surface (arrowheads in
A and B); laminin a2 mRNA
was restricted to the me-
ninges (C and D), whereas
laminin a4 mRNA was de-
tected in endothelial cells
within and outside the brain
(E and F) in a similar pattern
to that observed with the en-
dothelial cell–specific probe,
flk-1 (G and H). Bar, 25 mm.The Journal of Cell Biology, Volume 153, 2001 940
Figure 5. Confocal microscopy analysis for the expression of integrin a6 and b-dystroglycan in mouse brain blood vessels. A–C show
double staining for integrin a6 and b-dystroglycan (b-dys) showing mutually exclusive distributions. D–F show double staining for inte-
grin a6 and the parenchymal basement membrane component, laminin a1, localizing integrin a6 on the inner endothelial cell layer; in-
set in F shows integrin a6 expression at sites of mononuclear infiltration revealing discontinuous staining. G–I show double staining for
b-dystroglycan and the endothelial cell basement membrane–specific laminin a4, demonstrating b-dystroglycan expression on astrocyte
endfeet; the insets in G–I show a higher magnification of a single vessel. J–L show double staining for integrin b1 and laminin a4 show-
ing overlapping distribution patterns; the inset in K shows integrin b1 expression at sites of mononuclear infiltration, demonstrating
concentration on the inner endothelial cell layer, but also on infiltration cells, with weaker expression on the astrocyte endfeet. Bars:
(A–C) 80 mm; (D–L) 100 mm.Sixt et al. Laminins in T Cell Recruitment in EAE 941
activation with TNF-a and IL-1 (Fig. 6 B), whereas treat-
ment with the angiostatic agent, hydroxymethylprogester-
one, decreased expression (Fig. 6 B). Interestingly, lami-
nin a5 mRNA was also upregulated by TNF-a and to
lesser extent by IL-1, whereas the 12-kb laminin a5
mRNA increased compared with the controls after hy-
droxymethylprogesterone treatment (Fig. 6 B). bEND3
responded less intensely than sEND1 to either TNF or IL-1
activation, consistent with its capillary origin (Fig. 6 C).
We have shown in a previous study that bEND3 and
sEND1 do not express laminin a1 mRNA (Sorokin et al.,
1994); experiments performed here with specific probes
for laminin a2 and a3 mRNA also revealed no signal, even
after 6 d of exposure (data not shown).
Adhesion of Encephalitogenic T Cell 
Lines to Purified Laminins
To investigate whether encephalitogenic T cells were ca-
pable of interacting with endothelial cell laminins, SJL/N
mouse–derived T cell lines specific for the encephalitoge-
nic peptide (amino acids 139–153) of PLP were tested for
adhesion to mouse laminins 1, 2, and 8, and human laminin
10. T cells adhered weakly to the laminin a5 chain contain-
ing laminin 10 (11% of total cells added) and exhibited
minimal binding to the laminin a4 chain containing lami-
nin 8 (5%; Fig. 7 A). The parenchymal basement mem-
brane laminins 1 and 2 were not adhesive, even at high
coating concentrations (Fig. 7 A).
Upon stimulation of T cells with PMA, encephalitogenic
T cells bound principally to laminin 10 (60%) and showed
increased binding to laminin 8 (20%; Fig. 7 A). However,
no specific binding to laminins 1 or 2 could be induced,
even under conditions that maximally activate integrins
(10 mM Mn21). The differential adhesion of the T cells to
the different laminin isoforms was not due to either the
quality of the laminin preparations or their ability to bind
to the culture plates, as C2C12 myoblasts where found to
bind significantly (50–100% cell adhesion) to all four lami-
nin isoforms (Karosi, S., O. Wendler, and L. Sorokin,
manuscript in preparation). To ensure that the different
purified laminin isoforms bound with the same efficiency
to the plastic plates used in cell adhesion assays, the lami-
nins were labeled with 125I and coated under the same con-
ditions as applied for cell binding assays. It was shown that
all four laminin isoforms used in this study bound to the
plastic surfaces in a comparable and concentration-depen-
dent manner (data not shown).
Adhesion of encephalitogenic T cells to laminins 8 and
10 was inhibited in a concentration-dependent manner
with the function-blocking antibodies to integrin a6 chain
(GoH3) and the mouse integrin b1 chain (Ha2/5; data for
laminin 10 is shown in Fig. 7 B), indicating a6b1-mediated
binding to both laminin 8 and 10.
Discussion
We have shown previously that different mouse endothe-
lial cell lines express predominantly either laminin a4 or
a5 and that this expression pattern can be altered by the
growth or activation state of the cells (Sorokin et al., 1994,
1997a; Frieser et al., 1997), suggesting that the laminin iso-
forms containing these chains have different functions in
endothelial cell basement membranes. The data presented
here support this hypothesis. Further, we have shown for
the first time that mononuclear cells infiltrating the CNS
during the course of EAE encounter two biochemically
and functionally distinct basement membranes, the endo-
thelial and parenchymal basement membranes. To date,
most studies of EAE have concentrated on leukocyte–
endothelial cell interactions, revealing a4b1 and vascular
cell adhesion molecule 1 as significant players (Engelhardt
et al., 1998; Laschinger and Engelhardt, 2000), or the sub-
sequent penetration of the CNS, with little consideration
that after penetrating the endothelial cell monolayer infil-
trating cells still face two formidable and distinct extracel-
lular barriers. The localization of a perivascular cuff of in-
filtrating mononuclear cells surrounding blood vessels at
early stages of EAE allowed clear identification of the en-
dothelial cell and parenchymal basement membranes,
demonstrating that endothelial cell basement membranes
contain laminin a4 and/or a5 chains which are produced
by endothelial cells, whereas parenchymal basement mem-
Figure 6. Northern blot analysis for the expression of laminin
a1, a2, a4, and a5 mRNA in control and EAE (clinical score 41/
51) mouse brains (A), and for laminins a4 and a5 mRNA in
sEND1 (B) and bEND3 (C) mouse endothelial cell lines. Endo-
thelial cell lines were either untreated, activated with IL-1 or
transforming growth factor a (TNFa), or treated with hydroxy-
methylprogesterone (Progester.). Data in A for laminin a1 and
a2 is after 2 wk of exposure, for laminin a5 after 6 d of exposure,
and for laminin a4 after 24 h of exposure.The Journal of Cell Biology, Volume 153, 2001 942
branes contain laminin a1 and a2 produced by lepto-
meningeal cells and astrocytes, respectively (see Fig. 8 for
summary of data). Interestingly, mononuclear recruitment
in the perivascular space correlated with the laminin com-
position of the endothelial cell basement membrane: re-
cruitment of T cells occurred exclusively around endothe-
lial cell basement membranes containing laminin a4, but
not laminin a5, suggesting that laminins containing the
laminin a4 chain are permissive for T cell infiltration,
whereas those containing the laminin a5 chains are restric-
tive or inhibitory (Fig. 8). In vitro studies demonstrated
that this is probably due to high affinity integrin a6b1–
mediated binding of encephalitogenic T cells to laminin
10, which has been shown in other cells not to be condu-
cive to migration, whereas the labile, low affinity binding
to laminin 8 is more likely to support cell migration
(Goodman et al., 1989; von der Mark et al., 1999; Pedraza
et al., 2000). Whether this is the case with the encephalito-
genic T cell lines is currently under investigation.
Integrin a6b1 has been reported to be a specific receptor
for laminin 1 on several cell types, including T cells
(Shimizu et al., 1990; van de Wiel-van Kemenade et al.,
1992), and in some cells also mediates binding to laminin 2
(Chang et al., 1995). However, despite constitutive surface
expression of this integrin, the encephalitogenic T cell lines
could not be induced to bind the parenchymal basement
membrane laminins 1 and 2. Even maximal cell (PMA)
and integrin (Mn21) activation conditions were ineffective
in inducing binding to either of these laminins, demon-
strating that the presence of the a6b1 receptor is insuffi-
cient for ligand binding. The data also suggest that T cell
transmigration of the parenchymal basement membrane is
fundamentally different from transmigration of the endo-
thelial cell basement membrane. This has been suggested
by the results of several other studies which have shown
that additional activating agents or comigrating bystander
cells are necessary for the final entry of T cells into the
brain parenchyma. In macrophage-depleted (Tran et al.,
1998) and TNF-a2/2 (Körner et al., 1997; Riminton et al.,
1998) mice, infiltrating T cells cross the endothelium and
its basement membrane, but remain in the perivascular
space even during peak stages of EAE. Furthermore,
GFAP knockout mice, which show a disrupted association
of the astrocyte endfeet with blood vessels, exhibit an early
spreading of the infiltrating cells into the CNS parenchyma
during EAE (Liedtke et al., 1998). Our data suggest that
the parenchymal barrier breaks down in lesions only at ad-
vanced stages of inflammation in a process which is likely
to be dependent on the proteolytic activity of MMPs.
MMPs have been extensively studied in EAE (Chandler et
al., 1997; Madri and Graesser, 2000), demonstrating a sig-
nificant role for MMPMT-1/MMP2 (Graesser et al., 1998,
2000) and MMP9 (Dubois et al., 1999; Lichtinghagen et al.,
1999; Hartung and Kieseier, 2000) in T cell entry into and
residency in the parenchyma of the CNS, as well as in
demyelination. Although protease inhibitors have been
shown to reduce the severity or delay the onset of EAE, to
date no protease inhibitor has been shown to completely
ablate T cell migration into the perivascular space or the
brain parenchyma (Clements et al., 1997; Graesser et al.,
2000). Until now it was not clear that emigrating T cells
face more than just the subendothelial cell basement mem-
brane. Therefore, the results of the MMP inhibitor experi-
ments were interpreted as reduced transmigration across
the endothelial cell basement membrane. However, they
can equally well be explained by inhibition of transmigra-
tion across the parenchymal basement membrane. It now
remains to be determined whether the main targets of
MMP activity are components of the endothelial cell or the
parenchymal basement membrane.
One of the major laminin receptors, integrin a6b1, was
localized predominantly on the endothelial cells, where it
is likely to mediate interactions with the endothelial cell
laminins 8 and 10, whereas astrocyte endfeet appear to uti-
lize a different receptor for interactions with the parenchy-
mal laminins. b-Dystroglycan occurred predominantly on
astrocyte endfeet where no a6 integrin was detected, sug-
Figure 7.  (A) Specific binding of nonactivated (s) and PMA-acti-
vated (m) PLP-specific, encephalitogenic T cell lines to increas-
ing concentrations of the endothelial cell basement membrane
laminins 10 and 8, and the parenchymal basement membrane
laminins 1 and 2. Saturable T cell binding occurred only to lami-
nins 10 and 8; binding to laminins 1 and 2 could not be induced,
even under maximal integrin activation conditions (10 mM
Mn21). (B) Binding to 30 nM laminin 10 was completely inhibited
by antiintegrin a6 (GoH3) or antiintegrin b1 (Ha2/5), whereas
anti-CD45 antibody (30G12) had no effect. The same pattern of
results was observed for laminin 8. Values represent means of at
least six experiments 6 SD.Sixt et al. Laminins in T Cell Recruitment in EAE 943
gesting that a-dystroglycan may be the laminin receptor
on the astrocyte endfeet mediating binding to the paren-
chymal laminins 1 and 2. We have tested two a-dystrogly-
can antibodies, IIH6 and VIA4-1, both of which showed
extremely weak staining of the CNS blood vessels (data
not shown). Hence, it cannot be excluded from the data
represented here that b-dystroglycan alone occurs on the
astrocyte endfeet as has been shown in other tissues (Saito
et al., 1999; Losasso et al., 2000). We and others have
shown that during the course of EAE, integrin a6b1 is
downregulated on the endothelial cells at sites of infiltra-
tion (Defilippi et al., 1992; Sobel et al., 1998). This, in com-
bination with our observed high turnover of laminin a4 in
endothelial cell basement membranes in the brain and the
selective upregulation of laminin a4 expression by cyto-
kines such as TNF-a, which have been shown to play a role
in EAE, may lead to a loosening of the endothelial cell–
basement membrane interaction, resulting in the reported
“rounding up” of endothelial cells observed at sites of T
cell infiltration in EAE (Wolburg et al., 1999) and further
facilitating the infiltration process.
The clear identification of the endothelial cell and pa-
renchymal basement membranes possible in the present
study and characterization of their laminin isoform con-
tent clarifies confusion in the literature concerning laminin
distribution in blood vessels in the CNS. Both laminin a1
and a2 have been reported to be expressed by brain blood
vessels in noninflamed brains (Sanes et al., 1990; Jucker et
al., 1996; Virtanen et al., 2000). However, in the absence of
an inflammation, as shown here, the endothelial and pa-
renchymal basement membranes lie in such close proxim-
ity that at the light microscopy level they may be mistaken
for a single structure, leading to the misconception that
laminins a1 and a2 are present in endothelial cell base-
ment membranes. Further discrepancies may also result
from the fact that the laminin a1 monoclonal antibodies
used in earlier studies were subsequently shown to recog-
nize the laminin a5 chain (Virtanen et al., 1995; Jucker et
al., 1996; Tiger et al., 1997).
The process of extravasation in the CNS is frequently
described as passage through the blood–brain barrier
(BBB; Noseworthy, 1999), a structure characterized by in-
terendothelial cell tight junctions and induced and main-
tained by the close association between microvascular en-
dothelial cells and astrocyte endfeet processes (Janzer and
Raff, 1987; Wolburg and Risau, 1995). However, our data
clearly showed that T cell transmigration never occurred
at microvascular sites, but rather at postcapillary venules
where endothelial cells were separated from the astrocyte
endfeet by two basement membranes and at least one cell
layer (leptomeningeal cells). Therefore, this site does not
fulfill the above described characteristics of the BBB. The
association of epithelial leptomeningeal cells with veins
and postcapillary venules has not been reported previ-
ously, but may be related to the nature of the studies per-
formed to date: ultrastructural studies on human tissues
have shown that cerebral arteries and arterioles are en-
sheeted by leptomeningeal cells (Alcolado et al., 1988;
Zhang et al., 1990), but such studies cannot easily distin-
guish between vessel types. Only through the use of lami-
nin chain–specific antibodies and our knowledge of their
cellular origins, in combination with examination of in-
flamed brain tissue, was it possible to specifically define
the cell layers and basement membranes associated with
Figure 8. Illustration of cell
layers, basement membranes
(BM), and their laminin com-
position of CNS blood vessels
with and without an inflam-
matory cuff. Larger blood
vessels consist of an inner en-
dothelial cell layer with a
basement membrane (con-
taining laminins a4 and a5),
bordered by the meningeal
epithelium and its basement
membrane (containing lami-
nin  a1) and an outer astroglial
basement membrane (con-
taining laminin a2) and astro-
cyte endfeet. The meningeal
and astroglial basement
membranes are collectively
termed the parenchymal
basement membrane as they
delineate the border to the
brain parenchyma. Only at
sites of local inflammation
are the endothelial and parenchymal basement membranes distinguishable and define the inner and outer limits of the perivascular
space where leukocytes accumulate before infiltrating the brain parenchyma. Examination of such sites demonstrates that mononuclear
infiltration occurs across endothelial basement membranes containing only the laminin a4 and bordered by a parenchymal basement
membrane containing laminin a1 and a2. The basement membrane of microvessels where no epithelial meningeal contribution occurs
appear to have a composite basement membrane containing the endothelial cell laminins, laminin a4 and a5, and laminin a2 produced
by the astrocytes and deposited at their endfeet.The Journal of Cell Biology, Volume 153, 2001 944
sites of cellular infiltration. It now remains to be deter-
mined how the leptomeningeal sheet appears at the ultra-
structural level in postcapillary venules and veins in the
mouse brain, and the nature of the BBB at such sites.
In conclusion, our data enforce the concept that T cell
emigration of the endothelial cell basement membrane is
distinct from transmigration of the parenchymal basement
membrane. For the first time, two biochemically distinct
basement membranes encountered by emigrating T cells
in EAE have been defined, and not only laminin a4 in the
endothelial cell basement membrane and integrin a6 on
emigrating T cells, but also the endothelium of inflamed
vessels, have been identified as key players in transmigra-
tion of the endothelial basement membrane.
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